Observations placeholder
Rapaflo
Identifier
019993
Type of Spiritual Experience
Background
A description of the experience
Silodosin (trade names Rapaflo (USA), Silodyx (Europe and South Africa), Rapilif (India), Silodal (India), Urief (Japan), Urorec (Russia)) is a medication for the symptomatic treatment of benign prostatic hyperplasia. It acts as an α1-adrenoceptor antagonist with high uroselectivity (selectivity for the prostate).
On Jan, 09, 2017 1,714 people reported to have side effects when taking Rapaflo.
Among them, 13 people (0.76%) have Hallucination
Time on Rapaflo when people have Hallucination :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Hallucination | 100.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
On Jan, 29, 2016: 812 people reported to have side effects when taking Rapaflo. Among them, 26 people (3.20%) have Death.
Time on Rapaflo when people have Death :
< 1 month | 1 - 6 months | 6 - 12 months | 1 - 2 years | 2 - 5 years | 5 - 10 years | 10+ years | |
Death | 0.00% | 0.00% | 0.00% | 100.00% | 0.00% | 0.00% | 0.00% |